| MSCYX | VSGAX | MSCYX / VSGAX | |
| Total Expense Ratio | 1.05 | 0.07 | 1,500% |
| Annual Report Gross Expense Ratio | 1.08 | 0.07 | 1,543% |
| Fund Existence | 27 years | 15 years | - |
| Gain YTD | 23.843 | 18.861 | 126% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 700M | 43.9B | 2% |
| Annual Yield % from dividends | 0.00 | 0.44 | - |
| Returns for 1 year | 12.14 | 26.40 | 46% |
| Returns for 3 years | 35.54 | 62.74 | 57% |
| Returns for 5 years | -15.06 | 29.90 | -50% |
| Returns for 10 years | 29.13 | 176.24 | 17% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IPOCX | 20.44 | 0.41 | +2.05% |
| Nomura Systematic Emerging Markets Eq C | |||
| CSIRX | 32.49 | 0.38 | +1.18% |
| Columbia Acorn International Sel Inst3 | |||
| LHCVX | 25.30 | 0.25 | +1.00% |
| Lord Abbett Health Care R6 | |||
| CISIX | 64.14 | 0.30 | +0.47% |
| Calvert US Large Cap Core Rspnb Idx I | |||
| MRBPX | 23.87 | 0.10 | +0.42% |
| BlackRock Balanced R | |||